140 related articles for article (PubMed ID: 16987247)
1. Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopathies.
Ishikawa K; Kudo Y; Nishida N; Suemoto T; Sawada T; Iwaki T; Doh-ura K
J Neurochem; 2006 Oct; 99(1):198-205. PubMed ID: 16987247
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
3. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
[TBL] [Abstract][Full Text] [Related]
4. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
5. Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies.
Ishikawa K; Doh-Ura K; Kudo Y; Nishida N; Murakami-Kubo I; Ando Y; Sawada T; Iwaki T
J Gen Virol; 2004 Jun; 85(Pt 6):1785-1790. PubMed ID: 15166464
[TBL] [Abstract][Full Text] [Related]
6. Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies.
Sasaki K; Doh-ura K; Ironside JW; Iwaki T
Acta Neuropathol; 2002 Mar; 103(3):199-208. PubMed ID: 11907798
[TBL] [Abstract][Full Text] [Related]
7. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions.
Hervé R; Collin R; Pinchin HE; Secker T; Keevil CW
J Microbiol Methods; 2009 Apr; 77(1):90-7. PubMed ID: 19318058
[TBL] [Abstract][Full Text] [Related]
8. Failure to detect prion protein (PrPres) by immunohistochemistry in striated muscle tissues of animals experimentally inoculated with agents of transmissible spongiform encephalopathy.
Hamir AN; Miller JM; Cutlip RC
Vet Pathol; 2004 Jan; 41(1):78-81. PubMed ID: 14715973
[TBL] [Abstract][Full Text] [Related]
9. Neuroinvasion in sheep transmissible spongiform encephalopathies: the role of the haematogenous route.
Sisó S; Jeffrey M; González L
Neuropathol Appl Neurobiol; 2009 Jun; 35(3):232-46. PubMed ID: 19473292
[TBL] [Abstract][Full Text] [Related]
10. A special report I. Prion protein (Prp)--amyloid plaques in the transmissible spongiform encephalopathies (TSEs) or prion disease revisited.
Liberski PP; Bratosiewicz J; Waliś A; Kordek R; Jeffrey M; Brown P
Pol J Pathol; 2001; 52(4):169-86. PubMed ID: 11915178
[TBL] [Abstract][Full Text] [Related]
11. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases.
Bastian FO; Fermin CD
Microsc Res Tech; 2005 Nov; 68(3-4):239-46. PubMed ID: 16276518
[TBL] [Abstract][Full Text] [Related]
12. Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner.
Kawasaki Y; Kawagoe K; Chen CJ; Teruya K; Sakasegawa Y; Doh-ura K
J Virol; 2007 Dec; 81(23):12889-98. PubMed ID: 17881452
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
[TBL] [Abstract][Full Text] [Related]
14. Detection of misfolded prion protein in blood with conformationally sensitive peptides.
Pan T; Sethi J; Nelsen C; Rudolph A; Cervenakova L; Brown P; Orser CS
Transfusion; 2007 Aug; 47(8):1418-25. PubMed ID: 17655586
[TBL] [Abstract][Full Text] [Related]
15. PrP genetics in ruminant transmissible spongiform encephalopathies.
Goldmann W
Vet Res; 2008; 39(4):30. PubMed ID: 18284908
[TBL] [Abstract][Full Text] [Related]
16. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
Manuelidis L
J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-binding compounds and their anti-prion potency.
Teruya K; Doh-ura K
Curr Top Med Chem; 2013; 13(19):2522-32. PubMed ID: 24059333
[TBL] [Abstract][Full Text] [Related]
18. Rodent models for prion diseases.
Groschup MH; Buschmann A
Vet Res; 2008; 39(4):32. PubMed ID: 18284909
[TBL] [Abstract][Full Text] [Related]
19. Prion agent diversity and species barrier.
Béringue V; Vilotte JL; Laude H
Vet Res; 2008; 39(4):47. PubMed ID: 18519020
[TBL] [Abstract][Full Text] [Related]
20. Atypical transmissible spongiform encephalopathies (TSEs) in ruminants.
Baron T; Biacabe AG; Arsac JN; Benestad S; Groschup MH
Vaccine; 2007 Jul; 25(30):5625-30. PubMed ID: 17126958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
